Health Athenex 宣佈 Klisyri® (tirbanibulin) 從歐洲藥物管理局 (EMA) 的面部或頭皮光化性角化病治療中獲得人用醫藥產品委員會 (CHMP) 正面評價 James Pereira May 22, 2021 紐約水牛城, May 21, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX) 作為一家致力於新藥發現、開發和商業化的全球生物製藥公司,今天宣佈其合作夥伴 Almirall… Read More...
Health Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines… James Pereira May 22, 2021 BUFFALO, N.Y., May 21, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company… Read More...